Evidence map›Paper›PMID 33194812›Full record

ArticleFrontiers in cellular and infection microbiology2020

Epitopes for Multivalent Vaccines Against

Carmen Alvarez-Dominguez, David Salcines-Cuevas, Héctor Teran-Navarro, Ricardo Calderon-Gonzalez, Raquel Tobes, Isabel Garcia, Santiago Grijalvo, Alberto Paradela, Asunción Seoane, Felix J Sangari and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. TargetingVaccines · 2024
    Review
  3. Review
  4. Article
  5. A Comparison Between RecombinantFrontiers in immunology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 1 country.

Carmen Alvarez-DominguezGrupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
David Salcines-CuevasGrupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
Héctor Teran-NavarroGrupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
Ricardo Calderon-GonzalezGrupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
Raquel TobesIndependent Researcher, Granada, Spain.
Isabel GarciaBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
Santiago GrijalvoBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Barcelona, Spain.
Alberto ParadelaCentro Nacional de Biotecnología, CSIC, Madrid, Spain.
Asunción SeoaneDepartment of Molecular Biology, Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC, CSIC-Universidad de Cantabria-SODERCAN), Santander, Spain.
Felix J SangariDepartment of Molecular Biology, Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC, CSIC-Universidad de Cantabria-SODERCAN), Santander, Spain.
Manuel FresnoDepartment of Molecular Biology, DIOMUNE S.L., Madrid, Spain.
Jorge Calvo-MontesServicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
I Concepción Pérez Del Molino BernalServicio de Microbiología, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
Sonsoles Yañez-DiazGrupo de Oncología y Nanovacunas, Instituto de Investigación Marqués de Valdecilla, Santander, Spain.
Instituto de Investigación Marqués de Valdecilla · ESMarqués de Valdecilla University Hospital · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESCentro Nacional de Biotecnología · ESCIC biomaGUNE · ESInstituto de Biomedicina y Biotecnología de Cantabria · ESUniversidad Autónoma de Madrid · ESUniversidad de Cantabria · ESUniversidad Internacional De La Rioja · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The glycolytic enzyme and bacterial virulence factor of

Indexed as

ListeriaMycobacteriumAnimalsEpitopesGlyceraldehyde-3-Phosphate DehydrogenasesHumansMiceProteomicsStreptococcusVaccines, CombinedEpitopesGlyceraldehyde-3-Phosphate DehydrogenasesVaccines, Combinedadjuvantsglyceraldehyde-3-phosphate-dehydrogenaselisteriosispneumoniatuberculosisvaccines

Identifiers

PMID33194812
PMCPMC7657268
OpenAlexW3095529708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.